|
US2017199176A1
|
|
T cell populations in diagnosis, prognosis, prediction, and monitoring
|
|
WO2016138182A1
|
|
Methods and compositions for immunomodulation
|
|
WO2016036878A1
|
|
Methods for diagnosis, prognosis and methods of treatment
|
|
US2016223554A1
|
|
Methods for diagnosis, prognosis and methods of treatment
|
|
US2016245794A1
|
|
Methods and compositions for systemic lupus erythematosus
|
|
US2015309062A1
|
|
High throughput flow cytometry system and method
|
|
US2015118247A1
|
|
Methods and compositions for immunomodulation
|
|
US2015119288A1
|
|
Kits for multiparametric phospho analysis
|
|
US2015110736A1
|
|
Methods for determining the effects of compounds on jak/stat activity
|
|
WO2014134570A1
|
|
Compositions and methods for autoimmune disease
|
|
WO2014081987A1
|
|
Methods for diagnosis, prognosis and methods of treatment
|
|
US2014199273A1
|
|
Methods for diagnosis, prognosis and methods of treatment
|
|
WO2014074646A2
|
|
Induced intercellular communication
|
|
US2014134650A1
|
|
Induced intercellular communication
|
|
US2014040265A1
|
|
Method and apparatus for representing multidimensional data
|
|
WO2014036040A2
|
|
Methods for diagnosis, prognosis and methods of treatment
|
|
US2014057865A1
|
|
Analysis of nodes in cellular pathways
|
|
US2014011222A1
|
|
Multiple mechanisms for modulation of the p13 kinase pathway
|
|
US2014017678A1
|
|
Pathway characterization of cells
|
|
WO2013112948A1
|
|
Benchmarks for normal cell identification
|
